BMC Pulmonary Medicine (May 2024)

A novel entity of HIPK2::YAP1 pulmonary fibromatosis

  • Yuqiang Liu,
  • Meng Liang,
  • Kai Chen,
  • Lucas Wang,
  • Yaxian Yang,
  • Qi Li,
  • Bin Lian,
  • Tongxu Zhuo,
  • Jian Huang

DOI
https://doi.org/10.1186/s12890-024-03026-5
Journal volume & issue
Vol. 24, no. 1
pp. 1 – 4

Abstract

Read online

Abstract Background Pulmonary fibromatosis (PF) is a specific variant of fibromatosis, which is rarely reported occurring in the lung. PF with HIPK2-YAP1 fusion was a novel entity. Case presentation In this report, a 66-year-old male with PF had been smoking over 40 years. Multiple cords and small nodules in both lungs had been detected in a health examination two years earlier at our hospital. But approximately twofold enlarged in the lingual segment of the upper lobe in the left lung were disclosed in this year. Immunohistochemical analysis demonstrated that the vimentin and β-Catenin were positive in the largest nodule. After underwent a DNA/RNA panel next-generation sequencing (NGS), missense mutations and HIPK2-YAP1 fusion were found in this sample. Ultimately, the case diagnosis as PF with HIPK2-YAP1 fusion after multidisciplinary treatment. Currently, the patient is doing well and recurrence-free at 14 months post-surgery. Conclusions It’s difficult for patients with complex morphology to make accurate diagnosis solely based on morphology and immunohistochemistry. But molecular detection is an effective method for further determining pathological subtypes.

Keywords